Home > Press > Applied Nanotech Holdings, Inc. Adds Paul Rocheleau to Board of Directors
Abstract:
Applied Nanotech Holdings, Inc. (OTCBB: APNT) today announced that Paul F. Rocheleau was appointed to the Company's Board of Directors.
Mr. Rocheleau has extensive experience in the global materials and chemicals industry. Over the past three years, he provided strategic and financial advisory services for a range of technology and industrial companies as a Managing Director at Cary Street Partners, a regional investment banking firm based in Richmond, Virginia. Prior experience included positions as Senior VP and Chief Financial Officer of Albermarle Corporation, a $2.0 billion NYSE listed chemical company, and 15 years, including three as CEO, with Albright & Wilson, PLC, a $1.2 billion multinational chemical company.
Mr. Rocheleau currently serves on the Board of Directors of NanoChemonics, a specialty nano-materials company, and serves on the Advisory Board of Mikro Systems, Inc., a high-precision engineering and materials fabrication company. He also is a Founding Trustee of the Virginia Commonwealth University School of Engineering, where he currently serves as President of the Foundation.
"I want to welcome Paul to the Board," said Dr. Robert Ronstadt, Chairman of Applied Nanotech. "We are fortunate to find a Board Member of Paul's caliber. His extensive knowledge of the global materials and chemical industries will be invaluable to us in expanding our proprietary conductive inks, and specialty carbon nanotube composites business, while his broad business experience will be helpful in all areas."
####
About Applied Nanotech Holdings, Inc.
Applied Nanotech Holdings, Inc. is a premier research and commercialization organization focused on solving problems at the molecular level. Its team of PhD level scientists and engineers work with companies and other organizations to solve technical impasses and create innovations that will create a competitive advantage. It also possesses investments related to electronic digitized sign technology. Applied Nanotech has over 250 patents or patents pending and its business model is to license its technology to partners that will manufacture and distribute products using the technology.
SAFE HARBOR STATEMENT
This press release contains forward-looking statements that involve risks and uncertainties concerning our business, products, and financial results. Actual results may differ materially from the results predicted. More information about potential risk factors that could affect our business, products, and financial results are included in our annual report on Form 10-K for the fiscal year ended December 31, 2008, and in reports subsequently filed by us with the Securities and Exchange Commission ("SEC"). All documents are available through the SEC's Electronic Data Gathering Analysis and Retrieval System (EDGAR) at www.sec.gov or from our website listed above. We hereby disclaim any obligation to publicly update the information provided above, including forward-looking statements, to reflect subsequent events or circumstances.
For more information, please click here
Contacts:
Doug Baker
Applied Nanotech Holdings, Inc.
248.391.0612
Copyright © Marketwire
If you have a comment, please Contact us.Issuers of news releases, not 7th Wave, Inc. or Nanotechnology Now, are solely responsible for the accuracy of the content.
Related News Press |
News and information
Beyond wires: Bubble technology powers next-generation electronics:New laser-based bubble printing technique creates ultra-flexible liquid metal circuits November 8th, 2024
Nanoparticle bursts over the Amazon rainforest: Rainfall induces bursts of natural nanoparticles that can form clouds and further precipitation over the Amazon rainforest November 8th, 2024
Nanotechnology: Flexible biosensors with modular design November 8th, 2024
Exosomes: A potential biomarker and therapeutic target in diabetic cardiomyopathy November 8th, 2024
Announcements
Nanotechnology: Flexible biosensors with modular design November 8th, 2024
Exosomes: A potential biomarker and therapeutic target in diabetic cardiomyopathy November 8th, 2024
Turning up the signal November 8th, 2024
Nanofibrous metal oxide semiconductor for sensory face November 8th, 2024
Appointments/Promotions/New hires/Resignations/Deaths
Leibniz Prize winner Professor Dr. Oliver G. Schmidt moves to Chemnitz University of Technology: President Professor Dr. Gerd Strohmeier refers to an 'absolute top transfer' September 10th, 2021
JEOL USA Welcomes New Managing Director, Hidetaka Sawada April 19th, 2021
The National Space Society Remembers Ben Bova : NSS Mourns the Loss of a Visionary NSS Leader December 2nd, 2020
The latest news from around the world, FREE | ||
Premium Products | ||
Only the news you want to read!
Learn More |
||
Full-service, expert consulting
Learn More |
||